Literature DB >> 348647

Migraine prophylaxis with Lisuride hydrogen maleate--a double blind study of Lisuride versus placebo.

B W Somerville, W M Herrmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 348647     DOI： 10.1111/j.1526-4610.1978.hed1802075.x

Source DB:  PubMed          Journal:  Headache        ISSN： 0017-8748            Impact factor:   5.887


× No keyword cloud information.
  8 in total

1.  The pharmacokinetics and pharmacodynamics of lisuride in healthy volunteers after intravenous, intramuscular, and subcutaneous injection.

Authors:  W Krause; T Mager; G Kühne; T Duka; B Voet
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  A neuropharmacological analysis of the discriminative stimulus properties of fenfluramine.

Authors:  F J White; J B Appel
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

3.  Dihydroergotamine and its metabolite, 8'-hydroxy-dihydroergotamine, as 5-HT1A receptor agonists in the rat brain.

Authors:  N Hanoun; F Saurini; L Lanfumey; M Hamon; S Bourgoin
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

Review 4.  Current and prospective pharmacological targets in relation to antimigraine action.

Authors:  Suneet Mehrotra; Saurabh Gupta; Kayi Y Chan; Carlos M Villalón; David Centurión; Pramod R Saxena; Antoinette MaassenVanDenBrink
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-15       Impact factor: 3.000

5.  Activity of a non-hallucinogenic ergoline derivative, lisuride, in an animal behavior model for hallucinogens.

Authors:  J L Marini; B L Jacobs; M H Sheard; M E Trulson
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

Review 6.  Dopaminergic symptoms in migraine.

Authors:  Piero Barbanti; L Fofi; C Aurilia; G Egeo
Journal:  Neurol Sci       Date:  2013-05       Impact factor: 3.307

7.  Optimizing prophylactic treatment of migraine: Subtypes and patient matching.

Authors:  Michel Dib
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423

8.  LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT(2A) receptor.

Authors:  Adam L Halberstadt; Mark A Geyer
Journal:  Psychopharmacology (Berl)       Date:  2009-11-25       Impact factor: 4.530
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.